Taurine

Verdict: Suggestive — leaning toward downgrade Last reviewed: 2026-04-24 Triangulated against anchor: NMN (Suggestive)

TL;DR

The 2023 Yadav et al. Science paper showing taurine extends mouse lifespan by ~10-12% generated enormous attention. The follow-up has been notably negative: a 2025 Science analysis found taurine does not reliably decline with age — a foundational premise of the supplementation rationale — and large interindividual variation undercuts the simple "replenish what's lost" framing. No human RCTs exist. Verdict: Suggestive, with significant downgrade risk.

What it is

A sulfonic acid (technically not an amino acid by strict definition; commonly called a "conditionally essential amino acid"), abundant in animal tissues and present in many energy drinks. Synthesized endogenously from cysteine. Sold as supplement at 0.5-3g/day for longevity-curious users.

Proposed mechanism

Hypothesized: taurine declines with age → restoring tissue taurine improves mitochondrial function, reduces oxidative stress, restores tissue homeostasis. Specific mechanistic claims include effects on calcium signaling, bile acid metabolism, mitochondrial function, neurotransmitter modulation.

Confidence: Plausible for individual mechanisms (taurine is biologically active); Hypothetical for the specific aging claim — the foundational premise (age-related decline) is now contested.

Evidence ladder

Invertebrate (T5)

Taurine extended healthspan in C. elegans in Yadav 2023. Modest effects.

Mouse / rat (T4)

Yadav et al. 2023, Science — taurine supplementation extended median lifespan ~10-12% in mice (sex-dependent magnitude); improved various healthspan markers. Single-lab; published with high prominence.
Replication status: limited. As of early 2026, no major independent replication of the lifespan finding has been published. ITP has not (publicly) tested taurine yet.
Effect size: 10-12% median lifespan extension in the original paper.
Sex / strain / dose: Effects reported in both sexes; magnitude varied. Strain dependence not extensively characterized.

NHP (T4)

Yadav 2023 included rhesus monkey biomarker improvements (~6-month supplementation): improved metabolic, inflammatory markers. No lifespan data; healthspan biomarker only.

Human (T0-T2)

Observational — Yadav 2023 included epidemiological correlation of higher serum taurine with better aging biomarkers. Classic dietary-cohort confounding.
Critical 2025 reanalysis (Science, Fang et al. / NIA team) — analysis across multiple cohorts found taurine does not systematically decline with age in healthy individuals; large interindividual variation; concentrations often increase during adult life in many cohorts. This directly undermines a load-bearing premise of the original story.
No completed human RCTs of taurine supplementation for aging endpoints. Yadav himself has stated supplementation should wait for clinical trials.
Energy drink populations provide a "natural experiment" with high taurine intake; no clear longevity signal from those cohorts.

Confounds

The central premise (age-related taurine decline) is contested. The 2025 Science follow-up suggests the decline is not robust.
Single-lab original study without replication.
Healthy-user / dietary confounding in the human observational component.
Marketing pressure — taurine is cheap and widely available; supplement industry adopted it rapidly post-Yadav 2023, ahead of replication.

Conflict of interest scan

Yadav 2023 was independent academic work.
The 2025 critical follow-up was also independent.
Supplement industry interest exists but didn't generate the primary data.
No discount applied; the contestation here is scientific, not COI-driven.

Human translation

Honest read: taurine got a high-profile paper, the science press hyped it, and follow-up work has weakened the central premise. There is no human RCT evidence. Anyone supplementing taurine for longevity right now is doing so on the basis of one mouse study whose foundational premise (taurine declines with age) has been challenged.

This does not mean taurine "doesn't work" — the original mouse data is real and the lifespan extension number was meaningful. It means the case is much weaker than the popular narrative suggests, and the 2-year trajectory points downward.

Calibrated verdict

Suggestive — leaning downgrade. Per methodology, Suggestive is "T3 or T4 evidence with replication, but human data absent or null." Taurine fits T4 (single-lab mouse) without replication, no human data. It's at the bottom of the Suggestive band, not the top.

Compared to NMN (Suggestive), taurine has less replication (NR has been ITP-tested and failed; taurine hasn't been ITP-tested at all), less human RCT volume, and a contested foundational premise (NMN's NAD+-decline-with-age premise is well-established; taurine's decline premise is now disputed).

Compared to resveratrol (Mostly hype), taurine is not yet at the "tested at higher tier and failed" stage. ITP testing would be the decisive next step.

Confidence interval on verdict

Could move to Mostly hype if (a) ITP tests taurine and pooled results are null, OR (b) the 2025 critique of the age-related-decline premise gains broader acceptance, OR (c) human RCTs report null on hard endpoints. Plausible within 2 years.
Could move to Probable only with strong independent mouse replication AND positive human RCT on a hard or near-hard endpoint. Unlikely on the trial timeline.
Most likely 2-year trajectory: stays at Suggestive; moderate probability of downgrade to Mostly hype.

Open questions

Q: Is taurine being or going to be ITP-tested? (Add to QUESTIONS.md for resolver agent)
Q: Has any major lab independently replicated Yadav 2023's mouse lifespan finding? (Status as of 2026-Q2)
Q: Are there subpopulations where taurine genuinely declines and supplementation might be appropriate (e.g., sepsis recovery, aging cats — taurine is famously essential in cats)?
Q: Why did the original Yadav cohort show age-related decline when the NIA 2025 reanalysis did not? Methodological vs population-difference?

Sources

Produced under methodology locked 2026-04-24. Triangulated against NMN anchor.